drugs with semaglutide What's New in Obesity Treatment? The FDA approved a pill

FDA ramps up its pushback against compounded GLP-1s In a move that will delight Novo Nordisk and Eli Lilly, the FDA has sent warning letters to 30 telehealth companies, accusing them of illegally marketing compounded GLP-1 agonist formulations

That is why the patient journey matters so much with retatrutide

Gouroju S, Rao PV, Bitla AR, Vinapamula KS, Manohar SM, Vishnubhotla S

Despite reports of suicidality to the FAERS, a very large cross-sectional study conducted by the National Institutes of Health and Case Western Reserve, published in January 2023, showed a lower risk for suicidal ideation in those taking semaglutide compared with non-GLP-1 pharmacotherapy for obesity or diabetes

(-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of 1 adrenoceptor via GRK2 in experimental heart failure

the latter reached number seven on the pop chart